ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $23,532,000 | -59.9% | 8,170,973 | -37.4% | 0.30% | -46.9% |
| Q3 2017 | $58,652,000 | -2.5% | 13,062,900 | -0.3% | 0.56% | -11.1% |
| Q2 2017 | $60,162,000 | +9.0% | 13,107,200 | 0.0% | 0.63% | +1.0% |
| Q1 2017 | $55,181,000 | +1.9% | 13,107,200 | 0.0% | 0.62% | -9.4% |
| Q4 2016 | $54,133,000 | -49.0% | 13,107,200 | 0.0% | 0.69% | -42.9% |
| Q3 2016 | $106,168,000 | +16.5% | 13,107,200 | +12.2% | 1.21% | +27.1% |
| Q2 2016 | $91,116,000 | +0.7% | 11,681,600 | -0.3% | 0.95% | -0.1% |
| Q1 2016 | $90,476,000 | -13.1% | 11,719,700 | +21.4% | 0.95% | +1.0% |
| Q4 2015 | $104,122,000 | +188.5% | 9,649,900 | +84.8% | 0.94% | +159.1% |
| Q3 2015 | $36,087,000 | +2216.2% | 5,222,500 | +3205.4% | 0.36% | +2700.0% |
| Q1 2015 | $1,558,000 | -19.5% | 158,000 | 0.0% | 0.01% | -31.6% |
| Q4 2014 | $1,936,000 | +22.8% | 158,000 | 0.0% | 0.02% | +18.8% |
| Q3 2014 | $1,577,000 | -64.6% | 158,000 | -71.0% | 0.02% | -83.0% |
| Q2 2013 | $4,458,000 | – | 545,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |